Skip to main content

Dyslipidemias

  • Chapter
  • First Online:
Dermatology in Public Health Environments

Abstract

Cutaneous manifestations of systemic diseases can be an early sign or a late presentation of chronic disease. All practitioners should be familiar with common dermatologic lesions of generalized medical conditions so that they may properly diagnose and treat the patient or refer the patient to the proper specialist. This chapter addresses dyslipidemias and their epidemiology, etiopathogenesis, classification, and characteristic skin manifestation, namely, xanthomas. Being familiar with the clinical features, histopathology, and differential diagnosis of xanthomas helps to provide an early diagnosis and follow-up of different forms of dyslipidemia. Dermatologists must be aware that removing xanthomas is of no help if the underlying cause is not approached diagnostically and therapeutically.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Pai VV, Shukla P, Bhobe M. Combined planar and eruptive xanthoma in a patient with type lla hyperlipoproteinemia. Indian J Dermatol Venereol Leprol. 2014;80(5):467–70.

    Article  PubMed  Google Scholar 

  2. Massengale WT, Hodari KT, Boh EE, Nesbitt LT. Xanthomas. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. Philadelphia, Elsevier; 2012. p. 1547–55.

    Google Scholar 

  3. Gigante DP, Moura EC, Sardinha LM. Prevalence of overweight and obesity and associated factors, Brazil, 2006. Rev Saude Publica. 2009;43(2):83–9.

    Article  PubMed  Google Scholar 

  4. Bruckert E, Hansel B. Familial hypercholesterolemia (Part 1): diagnosis and screening challenges. In: Medscape [Internet]. Accessed 10 Apr 2016.

    Google Scholar 

  5. Paller AS, Mancini AJ. Inborn errors of metabolism. In: Hurwitz clinical pediatric dermatology. 4th ed. Philadelphia, Elsevier; 2011. p. 553–7.

    Google Scholar 

  6. Gao H, Chen J. Eruptive xanthomas presenting in tattoos. CMAJ. 2015;187(5):356.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Schaefer EJ, Santos RD. Xanthomatoses and lipoprotein disorders. In: Goldsmith LA, Katz SI, Gilchrest BA, et al., editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York, McGraw-Hill Companies; 2012. p. 1600–12.

    Google Scholar 

  8. Sethuraman G, Thappa DM, Karthikeyan K. Intertriginous xanthomas – a marker of homozygous familial hypercholesterolemia. Indian Pediatr. 2000;37:338.

    Google Scholar 

  9. Yamamoto A, Matsuzawa Y, Yokoyama S, et al. Effects of probucol on xanthomata regression in familial hypercholesterolemia. Am J Cardiol. 1986;57:29H–35H.

    Article  CAS  PubMed  Google Scholar 

  10. Bhagwat PV, Tophakhane RS, Kudligi C, Noronha TM, Thirunavukkarasu A. Familial combined hypercholesterolemia type IIb presenting with tuberous xanthoma, tendinous xanthoma and pityriasis rubra pilaris-like lesions. Indian J Dermatol Venereol Leprol. 2010;76(3):293–6.

    Article  PubMed  Google Scholar 

  11. Rohrs HJ, Berger S. Pediatric lipid disorders in clinical practice. In Medscape [Internet]. Accessed 10 Apr 2016.

    Google Scholar 

  12. Shenoy C, Shenoy MM, Rao GK. Dyslipidemia in dermatological disorders. N Am J Med Sci. 2015;7(10):421–8.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Vieira JLC, Vieira PL, Moriguchi EH. Hipolipemiantes. In: Barros E, Barros H. Medicamentos na prática clínica. 1st ed. Porto Alegre, Artmed; 2010. p. 288–303.

    Google Scholar 

  14. Rosenson RS, Freeman MW, Rind DM. Statins: actions, side effects, and administration. In: UpToDate [Internet]. WoltersKluwer Health. The Netherlands. Accessed 27 Mar 2016.

    Google Scholar 

  15. Rosenson RS, Freeman MW, Rind DM. Lipid lowering with fibric acid derivatives. In: UpToDate [Internet]. WoltersKluwer Health. The Netherlands. Accessed 27 Mar 2016.

    Google Scholar 

  16. Rosenson RS, Freeman MW, Rind DM. Lipid lowering with drugs other than statins and fibrates. In: UpToDate [Internet]. WoltersKluwer Health. The Netherlands. Accessed 27 Mar 2016.

    Google Scholar 

  17. Sando KR, Knight M. Therapies for management of dyslipidemia: a review. Clin Ther. 2015;37(10):2153–79.

    Article  CAS  PubMed  Google Scholar 

  18. White LE, Horenstein MG, Shea CR. Xanthomas. In Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I. Treatment of skin disease. 4th ed. Elsevier; Philadelphia, 2014. p 804–807

    Google Scholar 

  19. Goel K, Sardana K, Garg VK. A prospective study comparing ultrapulse CO2 laser and trichloroacetic acid in treatment of Xanthelasma palpebrarum. J Cosmet Dermatol. 2015;14(2):130–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cristiane Almeida Soares Cattani MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Cattani, C.A.S., Heck, R. (2018). Dyslipidemias. In: Bonamigo, R., Dornelles, S. (eds) Dermatology in Public Health Environments. Springer, Cham. https://doi.org/10.1007/978-3-319-33919-1_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33919-1_37

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33917-7

  • Online ISBN: 978-3-319-33919-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics